Pharma Surge
Pharma Surge
Intelligence Layer
🌍·Oct 12, 2024Media

Efficacy and Safety of Deep Transcranial Magnetic Stimulation Versus High-Frequency Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder: A Systematic Review

Publisher

B
BrainsWay

Global

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
BrainsWay
Region
Global
Scope
Media
Published
October 12, 2024

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on brainsway.com

Leave the platform to read the original full article on the publisher site.

Source: BrainsWay

Scope: Media

Open original article
Efficacy and Safety of Deep Transcranial Magnetic Stimulation Versus High-Frequency Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder: A Systematic Review | Pharma Surge